25 XP   0   0   10

Journey Medical Corp
Buy, Hold or Sell?

Let's analyse Journey Medical Corp together

PenkeI guess you are interested in Journey Medical Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Journey Medical Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Journey Medical Corp

I send you an email if I find something interesting about Journey Medical Corp.

Quick analysis of Journey Medical Corp (30 sec.)










What can you expect buying and holding a share of Journey Medical Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.9%

What is your share worth?

Current worth
$1.05
Expected worth in 1 year
$1.15
How sure are you?
29.4%

+ What do you gain per year?

Total Gains per Share
$0.10
Return On Investment
2.7%

For what price can you sell your share?

Current Price per Share
$3.54
Expected price per share
$2.85 - $5.05
How sure are you?
50%

1. Valuation of Journey Medical Corp (5 min.)




Live pricePrice per Share (EOD)

$3.54

Intrinsic Value Per Share

$-61.79 - $-73.95

Total Value Per Share

$-60.73 - $-72.90

2. Growth of Journey Medical Corp (5 min.)




Is Journey Medical Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$20.3m$29.8m-$18.5m-164.0%

How much money is Journey Medical Corp making?

Current yearPrevious yearGrowGrow %
Making money-$944.5k-$7.4m$6.4m684.2%
Net Profit Margin-24.1%-44.1%--

How much money comes from the company's main activities?

3. Financial Health of Journey Medical Corp (5 min.)




What can you expect buying and holding a share of Journey Medical Corp? (5 min.)

Welcome investor! Journey Medical Corp's management wants to use your money to grow the business. In return you get a share of Journey Medical Corp.

What can you expect buying and holding a share of Journey Medical Corp?

First you should know what it really means to hold a share of Journey Medical Corp. And how you can make/lose money.

Speculation

The Price per Share of Journey Medical Corp is $3.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Journey Medical Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Journey Medical Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.05. Based on the TTM, the Book Value Change Per Share is $0.02 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.51 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Journey Medical Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-3.1%-0.06-1.7%-0.39-11.0%-0.48-13.5%-0.84-23.8%
Usd Book Value Change Per Share0.236.4%0.020.7%-0.51-14.5%0.072.1%0.030.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.236.4%0.020.7%-0.51-14.5%0.082.1%0.030.9%
Usd Price Per Share5.76-2.92-3.24-1.76-0.88-
Price to Earnings Ratio-12.98--3.45--4.86--2.01--1.00-
Price-to-Total Gains Ratio25.36-5.49--6.39--0.25--0.25-
Price to Book Ratio5.47-1,434.53-1.89-338.09-169.04-
Price-to-Total Gains Ratio25.36-5.49--6.39--0.25--0.25-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.54
Number of shares282
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.020.07
Usd Total Gains Per Share0.020.08
Gains per Quarter (282 shares)6.7121.46
Gains per Year (282 shares)26.8685.83
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10271728476
2054443168162
3081715252248
40107987336334
501341259420420
6016115210505506
7018817912589592
8021520614673678
9024223316757764
10026926017841850

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%3.014.00.017.6%3.031.00.08.8%3.031.00.08.8%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.011.00.035.3%10.024.00.029.4%10.024.00.029.4%
Dividend per Share0.00.04.00.0%1.00.011.08.3%1.00.016.05.9%1.00.033.02.9%1.00.033.02.9%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%6.011.00.035.3%10.024.00.029.4%10.024.00.029.4%

Fundamentals of Journey Medical Corp

About Journey Medical Corp

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris; Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm cream and solution an antifungal intended for topical use; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; and Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. It also sells sulconazole nitrate cream and solution indicated for the treatment of tinea cruris, tinea corporis, and tinea versicolor; and doxycycline hyclate tablets, as an adjunctive therapy for severe acne. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.

Fundamental data was last updated by Penke on 2024-04-19 02:21:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Journey Medical Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Journey Medical Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -14.0% means that $-0.14 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Journey Medical Corp:

  • The MRQ is -14.0%. The company is making a huge loss. -2
  • The TTM is -24.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-14.0%TTM-24.1%+10.1%
TTM-24.1%YOY-44.1%+19.9%
TTM-24.1%5Y-216.4%+192.2%
5Y-216.4%10Y-2,537.1%+2,320.7%
1.1.2. Return on Assets

Shows how efficient Journey Medical Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.8% Return on Assets means that Journey Medical Corp generated $-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Journey Medical Corp:

  • The MRQ is -2.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.0%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-2.8%TTM0.0%-2.8%
TTM0.0%YOY-6.8%+6.9%
TTM0.0%5Y-6.1%+6.1%
5Y-6.1%10Y-9.5%+3.4%
1.1.3. Return on Equity

Shows how efficient Journey Medical Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • -10.5% Return on Equity means Journey Medical Corp generated $-0.11 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Journey Medical Corp:

  • The MRQ is -10.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41,827.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.5%TTM-41,827.0%+41,816.5%
TTM-41,827.0%YOY-31.5%-41,795.5%
TTM-41,827.0%5Y-9,880.7%-31,946.4%
5Y-9,880.7%10Y-4,954.4%-4,926.3%

1.2. Operating Efficiency of Journey Medical Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Journey Medical Corp is operating .

  • Measures how much profit Journey Medical Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -13.8% means the company generated $-0.14  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Journey Medical Corp:

  • The MRQ is -13.8%. The company is operating very inefficient. -2
  • The TTM is -21.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-13.8%TTM-21.7%+7.9%
TTM-21.7%YOY-41.1%+19.4%
TTM-21.7%5Y-197.5%+175.8%
5Y-197.5%10Y-2,449.0%+2,251.6%
1.2.2. Operating Ratio

Measures how efficient Journey Medical Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are $1.14 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Journey Medical Corp:

  • The MRQ is 1.138. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.171. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.138TTM1.171-0.033
TTM1.171YOY1.411-0.240
TTM1.1715Y3.010-1.839
5Y3.01010Y25.701-22.691

1.3. Liquidity of Journey Medical Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Journey Medical Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.35 means the company has $1.35 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Journey Medical Corp:

  • The MRQ is 1.348. The company is just able to pay all its short-term debts.
  • The TTM is 0.940. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.348TTM0.940+0.409
TTM0.940YOY1.337-0.397
TTM0.9405Y2.171-1.232
5Y2.17110Y5.916-3.745
1.3.2. Quick Ratio

Measures if Journey Medical Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.02 means the company can pay off $1.02 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Journey Medical Corp:

  • The MRQ is 1.019. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 0.661. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ1.019TTM0.661+0.358
TTM0.661YOY1.061-0.400
TTM0.6615Y2.566-1.905
5Y2.56610Y10.357-7.790

1.4. Solvency of Journey Medical Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Journey Medical Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Journey Medical Corp to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.74 means that Journey Medical Corp assets are financed with 73.5% credit (debt) and the remaining percentage (100% - 73.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Journey Medical Corp:

  • The MRQ is 0.735. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.848. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.735TTM0.848-0.113
TTM0.848YOY0.737+0.112
TTM0.8485Y0.840+0.008
5Y0.84010Y0.623+0.217
1.4.2. Debt to Equity Ratio

Measures if Journey Medical Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 277.6% means that company has $2.78 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Journey Medical Corp:

  • The MRQ is 2.776. The company is unable to pay all its debts with equity. -1
  • The TTM is 3,491.441. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.776TTM3,491.441-3,488.665
TTM3,491.441YOY3.126+3,488.316
TTM3,491.4415Y826.878+2,664.563
5Y826.87810Y414.052+412.826

2. Market Valuation of Journey Medical Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Journey Medical Corp generates.

  • Above 15 is considered overpriced but always compare Journey Medical Corp to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -12.98 means the investor is paying $-12.98 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Journey Medical Corp:

  • The EOD is -7.980. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.985. Based on the earnings, the company is expensive. -2
  • The TTM is -3.455. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.980MRQ-12.985+5.005
MRQ-12.985TTM-3.455-9.530
TTM-3.455YOY-4.859+1.404
TTM-3.4555Y-2.007-1.448
5Y-2.00710Y-1.003-1.003
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Journey Medical Corp:

  • The EOD is -1.041. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.694. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.074. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.041MRQ-1.694+0.653
MRQ-1.694TTM-0.074-1.620
TTM-0.074YOY-1.971+1.897
TTM-0.0745Y-0.731+0.658
5Y-0.73110Y-0.366-0.366
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Journey Medical Corp is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Journey Medical Corp:

  • The EOD is 3.362. Based on the equity, the company is fair priced.
  • The MRQ is 5.470. Based on the equity, the company is overpriced. -1
  • The TTM is 1,434.532. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD3.362MRQ5.470-2.108
MRQ5.470TTM1,434.532-1,429.062
TTM1,434.532YOY1.889+1,432.643
TTM1,434.5325Y338.086+1,096.445
5Y338.08610Y169.043+169.043
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Journey Medical Corp.

3.1. Institutions holding Journey Medical Corp

Institutions are holding 9.721% of the shares of Journey Medical Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30TANG CAPITAL MANAGEMENT LLC2.98130.22275761005761000
2023-12-31Renaissance Technologies Corp1.35070.00232610002401001148.8038
2023-12-31American Financial Group Inc0.93150.381418000000
2023-12-31Vanguard Group Inc0.669901294485678178.1386
2023-12-31EAM Investors, LLC0.57190.11291105091105090
2023-12-31Neuberger Berman Group LLC0.48890.000594479-16075-14.5404
2023-12-31Geode Capital Management, LLC0.44390.0001857851627623.4157
2023-12-31Millennium Management LLC0.38830.00027503160569418.8148
2023-12-31BlackRock Inc0.227104389229500204.975
2023-12-31Goss Wealth Management LLC0.18940.00193659224348198.8566
2023-12-31Perkins Capital Management Inc0.16560.157232000-192295-85.7331
2023-12-31Acadian Asset Management LLC0.14630.000628274282740
2023-12-31JANE STREET GROUP, LLC0.1436027749277490
2023-12-31Virtu Financial LLC0.13760.012126586265860
2023-12-31State Street Corporation0.132202555313700115.5826
2023-12-31Cubist Systematic Strategies, LLC0.12130.000923438234380
2023-12-31Brighton Jones LLC0.11910.00562302000
2023-12-31XTX Topco Ltd0.11770.028722737227370
2023-12-31Walleye Trading Advisors, LLC0.11490.000322200222000
2023-12-31Man Group PLC0.09450.000318268182680
Total 9.53570.92771842661+1088765+59.1%

3.2. Funds holding Journey Medical Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.9860.00011965238868382.2357
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.54730.000410908300
2023-12-31Pleiades Small Cap Equity A0.30110.038460012600120
2024-02-29Fidelity Extended Market Index0.22050.000543955-213-0.4822
2023-12-31Perkins Discovery0.11041.66182200000
2024-03-31BlackRock Extended Equity Market K0.1030.00052053670.0341
2024-02-29Fidelity Total Market Index0.08340.00011663100
2024-03-28iShares Micro-Cap ETF0.07260.00581447900
2024-03-29Royce Quant Small-Cap Quality Value ETF0.06350.16011265400
2024-02-29Fidelity Series Total Market Index0.05610.000111186-493-4.2213
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.05070.000910109101090
2024-02-29Fidelity Nasdaq Composite Index0.04350.0002867400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04070.0009811981190
2024-03-31NT Ext Equity Mkt Idx Fd - L0.03080.0004614000
2023-12-31Northern Trust Extended Eq Market Idx0.03080.000661403333118.7389
2024-02-29Spartan Total Market Index Pool E0.02410.0001479700
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02330.0001464200
2024-02-29Spartan Extended Market Index Pool E0.01890.000637702135.9882
2024-03-31Extended Equity Market Fund M0.01270.00052533-5-0.197
2024-02-291290 VT Micro Cap K0.00550.003110300
Total 2.82491.8751563086+169765+30.1%

3.3. Insider Transactions

Insiders are holding 29.911% of the shares of Journey Medical Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-25Lindsay A Md RosenwaldBUY100003.04
2024-03-22Claude MaraouiBUY100003.48
2024-03-22Justin Adam SmithBUY300003.47
2024-02-22Joseph BeneschSELL24503.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Journey Medical Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2270.024+854%-0.515+327%0.075+205%0.031+633%
Book Value Per Share--1.0530.575+83%1.708-38%0.991+6%3.222-67%
Current Ratio--1.3480.940+44%1.337+1%2.171-38%5.916-77%
Debt To Asset Ratio--0.7350.848-13%0.7370%0.840-12%0.623+18%
Debt To Equity Ratio--2.7763491.441-100%3.126-11%826.878-100%414.052-99%
Dividend Per Share----0%-0%0.002-100%0.001-100%
Eps---0.111-0.062-44%-0.389+250%-0.478+331%-0.844+661%
Free Cash Flow Per Share---0.850-0.018-98%-0.763-10%-0.352-59%-0.571-33%
Free Cash Flow To Equity Per Share--0.139-0.082+159%-0.526+478%0.163-15%0.413-66%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.023-2%
Intrinsic Value_10Y_max---73.953--------
Intrinsic Value_10Y_min---61.786--------
Intrinsic Value_1Y_max---2.035--------
Intrinsic Value_1Y_min---1.996--------
Intrinsic Value_3Y_max---10.212--------
Intrinsic Value_3Y_min---9.666--------
Intrinsic Value_5Y_max---23.327--------
Intrinsic Value_5Y_min---21.299--------
Market Cap49320342.000-126%111305963.52056381633.118+97%56578304.870+97%30987972.115+259%15493986.057+618%
Net Profit Margin---0.140-0.241+72%-0.441+214%-2.164+1440%-25.371+17963%
Operating Margin---0.138-0.217+57%-0.411+198%-1.975+1332%-24.490+17659%
Operating Ratio--1.1381.171-3%1.411-19%3.010-62%25.701-96%
Pb Ratio3.362-63%5.4701434.532-100%1.889+190%338.086-98%169.043-97%
Pe Ratio-7.980+39%-12.985-3.455-73%-4.859-63%-2.007-85%-1.003-92%
Price Per Share3.540-63%5.7602.915+98%3.238+78%1.764+227%0.882+553%
Price To Free Cash Flow Ratio-1.041+39%-1.694-0.074-96%-1.971+16%-0.731-57%-0.366-78%
Price To Total Gains Ratio15.586-63%25.3605.493+362%-6.394+125%-0.245+101%-0.245+101%
Quick Ratio--1.0190.661+54%1.061-4%2.566-60%10.357-90%
Return On Assets---0.0280.000-5844%-0.068+144%-0.061+118%-0.095+241%
Return On Equity---0.105-418.270+397091%-0.315+199%-98.807+93727%-49.544+46947%
Total Gains Per Share--0.2270.024+854%-0.515+327%0.076+199%0.032+616%
Usd Book Value--20350000.00011305250.000+80%29849750.000-32%22579764.706-10%104228294.118-80%
Usd Book Value Change Per Share--0.2270.024+854%-0.515+327%0.075+205%0.031+633%
Usd Book Value Per Share--1.0530.575+83%1.708-38%0.991+6%3.222-67%
Usd Dividend Per Share----0%-0%0.002-100%0.001-100%
Usd Eps---0.111-0.062-44%-0.389+250%-0.478+331%-0.844+661%
Usd Free Cash Flow---16428999.00082750.250-19954%-13383500.000-19%-11163941.118-32%-21045794.088+28%
Usd Free Cash Flow Per Share---0.850-0.018-98%-0.763-10%-0.352-59%-0.571-33%
Usd Free Cash Flow To Equity Per Share--0.139-0.082+159%-0.526+478%0.163-15%0.413-66%
Usd Market Cap49320342.000-126%111305963.52056381633.118+97%56578304.870+97%30987972.115+259%15493986.057+618%
Usd Price Per Share3.540-63%5.7602.915+98%3.238+78%1.764+227%0.882+553%
Usd Profit---2143000.000-944500.000-56%-7407000.000+246%-12663764.706+491%-29529823.529+1278%
Usd Revenue--15257000.00019795250.000-23%18417250.000-17%18810823.529-19%12092617.647+26%
Usd Total Gains Per Share--0.2270.024+854%-0.515+327%0.076+199%0.032+616%
 EOD+2 -6MRQTTM+24 -9YOY+22 -115Y+23 -1210Y+22 -14

4.2. Fundamental Score

Let's check the fundamental score of Journey Medical Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.980
Price to Book Ratio (EOD)Between0-13.362
Net Profit Margin (MRQ)Greater than0-0.140
Operating Margin (MRQ)Greater than0-0.138
Quick Ratio (MRQ)Greater than11.019
Current Ratio (MRQ)Greater than11.348
Debt to Asset Ratio (MRQ)Less than10.735
Debt to Equity Ratio (MRQ)Less than12.776
Return on Equity (MRQ)Greater than0.15-0.105
Return on Assets (MRQ)Greater than0.05-0.028
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Journey Medical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.297
Ma 20Greater thanMa 503.824
Ma 50Greater thanMa 1003.803
Ma 100Greater thanMa 2004.692
OpenGreater thanClose3.500
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Interest Income  -56739-528-149-677417-26034989
Total Other Income Expense Net -63459-575-2,601-3,1763,075-10118887



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets76,849
Total Liabilities56,499
Total Stockholder Equity20,350
 As reported
Total Liabilities 56,499
Total Stockholder Equity+ 20,350
Total Assets = 76,849

Assets

Total Assets76,849
Total Current Assets56,455
Long-term Assets20,394
Total Current Assets
Cash And Cash Equivalents 27,439
Net Receivables 15,222
Inventory 10,206
Other Current Assets 3,588
Total Current Assets  (as reported)56,455
Total Current Assets  (calculated)56,455
+/-0
Long-term Assets
Property Plant Equipment 101
Intangible Assets 20,287
Long-term Assets Other 6
Long-term Assets  (as reported)20,394
Long-term Assets  (calculated)20,394
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities41,868
Long-term Liabilities14,631
Total Stockholder Equity20,350
Total Current Liabilities
Short-term Debt 3,099
Accounts payable 18,344
Other Current Liabilities 20,372
Total Current Liabilities  (as reported)41,868
Total Current Liabilities  (calculated)41,815
+/- 53
Long-term Liabilities
Long term Debt 14,622
Capital Lease Obligations 108
Long-term Liabilities  (as reported)14,631
Long-term Liabilities  (calculated)14,730
+/- 99
Total Stockholder Equity
Common Stock2
Retained Earnings -72,355
Other Stockholders Equity 92,703
Total Stockholder Equity (as reported)20,350
Total Stockholder Equity (calculated)20,350
+/-0
Other
Capital Stock2
Cash and Short Term Investments 27,439
Common Stock Shares Outstanding 19,324
Current Deferred Revenue53
Liabilities and Stockholders Equity 76,849
Net Debt -9,709
Net Invested Capital 34,972
Net Working Capital 14,587
Property Plant and Equipment Gross 101
Short Long Term Debt Total 17,730



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-31
> Total Assets 
178,221
165,611
151,444
247,202
221,932
196,802
306,626
311,501
312,601
455,771
707,788
674,449
560,794
505,857
487,445
409,922
344,321
461,575
447,266
436,241
0
0
51,906
0
72,725
89,059
97,284
120,901
113,496
108,145
105,160
95,853
69,747
65,918
76,849
76,84965,91869,74795,853105,160108,145113,496120,90197,28489,05972,725051,90600436,241447,266461,575344,321409,922487,445505,857560,794674,449707,788455,771312,601311,501306,626196,802221,932247,202151,444165,611178,221
   > Total Current Assets 
105,463
124,490
122,529
224,188
217,233
193,196
303,325
273,508
283,991
433,339
698,710
670,651
556,614
502,087
447,318
393,184
335,409
443,008
428,470
412,519
0
0
35,242
0
53,473
66,795
84,493
90,259
83,901
79,596
77,679
60,720
47,679
44,686
56,455
56,45544,68647,67960,72077,67979,59683,90190,25984,49366,79553,473035,24200412,519428,470443,008335,409393,184447,318502,087556,614670,651698,710433,339283,991273,508303,325193,196217,233224,188122,529124,490105,463
       Cash And Cash Equivalents 
55,358
52,144
32,713
120,276
107,242
92,371
210,981
55,656
41,793
201,917
418,308
393,631
295,923
288,568
176,307
144,976
104,976
201,693
103,155
74,903
0
0
8,246
0
12,176
21,689
49,081
41,331
38,142
34,891
32,003
17,349
8,230
24,749
27,439
27,43924,7498,23017,34932,00334,89138,14241,33149,08121,68912,17608,2460074,903103,155201,693104,976144,976176,307288,568295,923393,631418,308201,91741,79355,656210,98192,371107,242120,27632,71352,14455,358
       Short-term Investments 
41,793
70,332
87,693
94,740
107,451
96,932
86,880
275,862
270,643
432,044
694,193
661,019
255,070
207,225
260,620
233,923
208,064
186,137
222,014
283,231
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000283,231222,014186,137208,064233,923260,620207,225255,070661,019694,193432,044270,643275,86286,88096,932107,45194,74087,69370,33241,793
       Net Receivables 
7,300
0
0
7,300
0
0
0
25,000
21,400
10,700
0
0
52
57
56
2,114
5,724
8,450
59,795
11,057
0
0
23,928
0
26,193
31,738
23,112
31,183
28,671
28,533
28,208
27,616
16,737
7,989
15,222
15,2227,98916,73727,61628,20828,53328,67131,18323,11231,73826,193023,9280011,05759,7958,4505,7242,1145657520010,70021,40025,0000007,300007,300
       Other Current Assets 
1,012
2,014
2,123
1,872
2,540
3,893
5,464
-83,010
-49,845
-211,322
-413,791
-383,999
5,569
6,237
10,233
9,252
8,275
33,373
25,862
19,820
0
0
1,664
0
789
1,754
2,438
1,608
1,035
942
3,309
2,477
1,796
924
3,588
3,5889241,7962,4773,3099421,0351,6082,4381,75478901,6640019,82025,86233,3738,2759,25210,2336,2375,569-383,999-413,791-211,322-49,845-83,0105,4643,8932,5401,8722,1232,0141,012
   > Long-term Assets 
72,758
41,121
28,915
23,014
4,699
3,606
3,301
37,993
28,610
22,432
9,078
3,798
4,180
3,770
40,127
16,738
8,912
18,567
18,796
23,722
0
0
16,664
0
19,252
22,264
12,791
30,642
29,595
28,549
27,481
35,133
22,068
21,232
20,394
20,39421,23222,06835,13327,48128,54929,59530,64212,79122,26419,252016,6640023,72218,79618,5678,91216,73840,1273,7704,1803,7989,07822,43228,61037,9933,3013,6064,69923,01428,91541,12172,758
       Property Plant Equipment 
192
177
223
284
386
460
435
413
1,127
1,092
1,003
929
1,433
1,500
1,395
1,300
1,180
14,942
14,008
13,118
0
0
175
0
133
111
89
67
45
22
189
167
146
124
101
1011241461671892245678911113301750013,11814,00814,9421,1801,3001,3951,5001,4339291,0031,0921,127413435460386284223177192
       Goodwill 
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
771
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000771771771771771771771771771771771771771771771771771771771771
       Intangible Assets 
3,520
3,520
3,520
3,520
1,126
1,126
1,126
1,126
1,126
1,126
1,126
1,126
1,126
0
1,000
976
952
927
903
879
0
0
15,029
0
13,701
13,043
12,552
30,457
29,440
28,424
27,197
26,128
21,916
21,102
20,287
20,28721,10221,91626,12827,19728,42429,44030,45712,55213,04313,701015,029008799039279529761,00001,1261,1261,1261,1261,1261,1261,1261,1261,1263,5203,5203,5203,520
       Long-term Assets Other 
2,608
985
1,002
998
1,397
1,249
969
961
1,035
1,013
992
972
850
1,499
1,394
2,862
3,047
1,927
1,117
6,925
0
0
6
0
149
749
150
118
110
103
95
8,838
6
6
6
6668,8389510311011815074914906006,9251,1171,9273,0472,8621,3941,4998509729921,0131,0359619691,2491,3979981,0029852,608
> Total Liabilities 
24,642
24,752
26,243
32,446
36,457
36,936
35,704
60,632
65,231
50,675
335,379
475,722
411,145
377,984
374,998
356,075
353,360
386,981
381,710
421,761
0
0
41,614
0
73,517
100,768
55,241
79,463
78,701
81,961
88,178
88,361
69,742
48,544
56,499
56,49948,54469,74288,36188,17881,96178,70179,46355,241100,76873,517041,61400421,761381,710386,981353,360356,075374,998377,984411,145475,722335,37950,67565,23160,63235,70436,93636,45732,44626,24324,75224,642
   > Total Current Liabilities 
11,890
11,996
12,926
19,307
25,896
26,641
25,387
28,699
34,992
21,311
28,603
143,261
105,358
97,078
93,647
74,276
38,556
62,094
50,873
58,638
0
0
28,061
0
44,409
59,790
51,606
60,970
60,100
60,777
66,832
76,898
68,193
48,510
41,868
41,86848,51068,19376,89866,83260,77760,10060,97051,60659,79044,409028,0610058,63850,87362,09438,55674,27693,64797,078105,358143,26128,60321,31134,99228,69925,38726,64125,89619,30712,92611,99611,890
       Short-term Debt 
635
0
0
200
1,072
0
0
0
3,022
0
0
0
4,625
0
0
0
0
4,187
4,220
4,255
0
0
85
0
94
96
910
74
49
25
3,031
13,007
10,037
97
3,099
3,0999710,03713,0073,0312549749109694085004,2554,2204,18700004,6250003,0220001,07220000635
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
812
0
0
0
2,948
12,914
9,942
0
0
009,94212,9142,94800081200000000000000000000000000
       Accounts payable 
5,563
6,783
5,648
6,769
9,230
12,540
8,796
6,226
13,500
5,406
8,476
9,741
15,094
10,580
12,345
13,465
15,948
6,081
11,549
11,247
0
0
1,839
0
4,245
28,180
22,812
26,959
32,750
33,626
36,570
43,658
31,773
28,164
18,344
18,34428,16431,77343,65836,57033,62632,75026,95922,81228,1804,24501,8390011,24711,5496,08115,94813,46512,34510,58015,0949,7418,4765,40613,5006,2268,79612,5409,2306,7695,6486,7835,563
       Other Current Liabilities 
-4,308
-4,787
-2,722
2,338
5,594
4,101
6,591
19,175
14,205
11,640
15,862
129,255
80,651
86,418
81,302
60,811
22,608
21,826
20,029
23,026
0
0
4,522
0
3,861
4,433
27,884
29,143
22,442
22,202
22,240
20,233
2,333
3,000
20,372
20,3723,0002,33320,23322,24022,20222,44229,14327,8844,4333,86104,5220023,02620,02921,82622,60860,81181,30286,41880,651129,25515,86211,64014,20519,1756,5914,1015,5942,338-2,722-4,787-4,308
   > Long-term Liabilities 
12,752
12,756
13,317
13,139
10,561
10,295
10,317
31,933
30,239
29,364
306,776
306,171
305,787
280,906
281,351
281,799
314,804
324,887
330,837
363,123
0
0
13,553
0
29,108
40,978
3,635
18,493
18,601
21,184
21,346
11,463
1,549
34
14,631
14,631341,54911,46321,34621,18418,60118,4933,63540,97829,108013,55300363,123330,837324,887314,804281,799281,351280,906305,787306,171306,77629,36430,23931,93310,31710,29510,56113,13913,31712,75612,752
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,287
4,365
8
0
0
0
0
0
0
0
0
0000000084,3654,287000000000000000000000000
> Total Stockholder Equity
153,579
140,859
125,201
214,756
185,475
159,866
270,922
250,869
247,370
405,096
372,409
198,727
149,649
127,873
112,447
53,847
-9,039
74,594
65,556
14,480
0
0
10,292
0
-792
-11,709
42,043
41,438
34,795
26,184
16,982
7,492
5
17,374
20,350
20,35017,37457,49216,98226,18434,79541,43842,043-11,709-792010,2920014,48065,55674,594-9,03953,847112,447127,873149,649198,727372,409405,096247,370250,869270,922159,866185,475214,756125,201140,859153,579
   Common Stock
25
25
25
30
30
30
35
36
36
42
42
42
42
42
42
42
42
54
54
55
0
0
1
0
1
1
2
2
2
2
2
2
2
2
2
2222222221101005554544242424242424242363635303030252525
   Retained Earnings Total Equity00-87,00100000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-211
-32
-99
-22
-97
48
43
-99
-252
-175
-211
-86
-215
-343
-170
-151
0
31
113
128
0
0
0
0
0
-18,078
0
0
0
0
0
0
0
0
0
000000000-18,07800000128113310-151-170-343-215-86-211-175-252-994348-97-22-99-32-211
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
87,004
0
0
0087,00400000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000
   Other Stockholders Equity 
58,193
237,550
239,118
344,645
346,590
349,272
488,083
493,681
497,718
684,870
690,785
696,152
703,215
710,926
719,259
727,033
735,957
884,410
893,334
899,878
0
0
5,171
0
5,684
5,413
80,915
81,688
82,573
84,042
85,482
86,128
87,004
87,584
92,703
92,70387,58487,00486,12885,48284,04282,57381,68880,9155,4135,68405,17100899,878893,334884,410735,957727,033719,259710,926703,215696,152690,785684,870497,718493,681488,083349,272346,590344,645239,118237,55058,193



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue79,181
Cost of Revenue-26,660
Gross Profit52,52152,521
 
Operating Income (+$)
Gross Profit52,521
Operating Expense-51,451
Operating Income1,0701,070
 
Operating Expense (+$)
Research Development7,541
Selling General Administrative48,056
Selling And Marketing Expenses0
Operating Expense51,45155,597
 
Net Interest Income (+$)
Interest Income259
Interest Expense-1,698
Other Finance Cost-593
Net Interest Income-2,032
 
Pretax Income (+$)
Operating Income1,070
Net Interest Income-2,032
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,6325,772
EBIT - interestExpense = -628
-3,632
-2,155
Interest Expense1,698
Earnings Before Interest and Taxes (EBIT)1,070-1,934
Earnings Before Interest and Taxes (EBITDA)4,925
 
After tax Income (+$)
Income Before Tax-3,632
Tax Provision-108
Net Income From Continuing Ops-12,352-3,740
Net Income-3,853
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses78,111
Total Other Income/Expenses Net-4,7022,032
 

Technical Analysis of Journey Medical Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Journey Medical Corp. The general trend of Journey Medical Corp is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Journey Medical Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Journey Medical Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.57 < 4.6358 < 5.05.

The bearish price targets are: 3.19 > 3.13 > 2.85.

Tweet this
Journey Medical Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Journey Medical Corp. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Journey Medical Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Journey Medical Corp. The current macd is -0.04857595.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Journey Medical Corp price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Journey Medical Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Journey Medical Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Journey Medical Corp Daily Moving Average Convergence/Divergence (MACD) ChartJourney Medical Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Journey Medical Corp. The current adx is 17.26.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Journey Medical Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Journey Medical Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Journey Medical Corp. The current sar is 3.4.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Journey Medical Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Journey Medical Corp. The current rsi is 45.30. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Journey Medical Corp Daily Relative Strength Index (RSI) ChartJourney Medical Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Journey Medical Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Journey Medical Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Journey Medical Corp Daily Stochastic Oscillator ChartJourney Medical Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Journey Medical Corp. The current cci is -75.09111518.

Journey Medical Corp Daily Commodity Channel Index (CCI) ChartJourney Medical Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Journey Medical Corp. The current cmo is -14.68463517.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Journey Medical Corp Daily Chande Momentum Oscillator (CMO) ChartJourney Medical Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Journey Medical Corp. The current willr is -82.32907588.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Journey Medical Corp Daily Williams %R ChartJourney Medical Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Journey Medical Corp.

Journey Medical Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Journey Medical Corp. The current atr is 0.4039167.

Journey Medical Corp Daily Average True Range (ATR) ChartJourney Medical Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Journey Medical Corp. The current obv is 9,300,599.

Journey Medical Corp Daily On-Balance Volume (OBV) ChartJourney Medical Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Journey Medical Corp. The current mfi is 63.17.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Journey Medical Corp Daily Money Flow Index (MFI) ChartJourney Medical Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Journey Medical Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Journey Medical Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Journey Medical Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.297
Ma 20Greater thanMa 503.824
Ma 50Greater thanMa 1003.803
Ma 100Greater thanMa 2004.692
OpenGreater thanClose3.500
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Journey Medical Corp with someone you think should read this too:
  • Are you bullish or bearish on Journey Medical Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Journey Medical Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Journey Medical Corp

I send you an email if I find something interesting about Journey Medical Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Journey Medical Corp.

Receive notifications about Journey Medical Corp in your mailbox!